Publications of Sven Göbel

Journal Article (2)

2022
Journal Article
Göbel, S., Kortum, F., Chavez, K. J., Jordan, I., Sandig, V., Reichl, U., Altomonte, J., & Genzel, Y. (2022)Cell-line screening and process development for a fusogenic oncolytic virus in small-scale suspension culturesApplied Microbiology and Biotechnology, 106, 4945–4961doi: 10.1007/s00253-022-12027-5.
2021
Journal Article
Gränicher, G., Babakhani, M., Göbel, S., Jordan, I., Marichal-Gallardo, P., Genzel, Y., & Reichl, U. (2021)A high cell density perfusion process for Modified Vaccinia virus Ankara production: process integration with inline DNA digestion and cost analysisBiotechnology and Bioengineering, 118 (12), 4720–4734doi: 10.1002/bit.27937.

Book Chapter (2)

2022
Book Chapter
Göbel, S., Pelz, L., Reichl, U., & Genzel, Y. (2022)Upstream processing for viral vaccines-Process intensificationBioprocessing of Viral Vaccines37 pages.
Book Chapter
Pelz, L., Göbel, S., Jaen , K., Reichl, U., & Genzel, Y. (2022)Upstream processing for viral vaccines–General aspectsBioprocessing of Viral Vaccines57 pages.

Meeting Abstract (2)

2022
Meeting Abstract
Göbel, S., Dorn, M., Jaén Chavez, K., Jordan, I., Sandig, V., Altomonte, J., Genzel, Y., & Reichl, U. (2022)Production of a fusogenic oncolytic rVSV-NDV virus in perfusion processesIn: Proceedings Vaccine Technology VIII, 60.
Meeting Abstract
Göbel, S., Pelz, L., Behrendt, I., Prömmel, M., Altomonte, J., Anderlei, T., Bürgin, T., Genzel, Y., & Reichl, U. (2022)Scale-Down of an Ortbital Shaken Bioreactor: High Cell Density Cultivation in Perfusion Mode and Virus productionIn: Proceedings Single-Use Technologies V: Building the Future, 40.

Talk (3)

2022
Talk
Göbel, S., Pelz, L., Behrendt, I., Prömmel, M., Altomonte, J., Anderlei, T., Bürgin, T., Genzel, Y., & Reichl, U.Scale-Down of an Ortbital Shaken Bioreactor: High Cell Density Cultivation in Perfusion Mode and Virus productionPresented at: Single-Use Technologies V: Building the FutureMarseille, France, March 20, 2022.
Talk
Gränicher, G., Göbel, S., Marichal-Gallardo, P., Jordan, I., Sandig, V., Genzel, Y., & Reichl, U.Integrated cell-culture based MVA virus production process with perfusion mode for vaccines or gene therapyPresented at: Value through intensified bioprocessing IIOxford, United Kingdom, June 22, 2022.
Talk
Gränicher, G., Göbel, S., Marichal-Gallardo, P., Jordan, I., Sandig, V., Genzel, Y., & Reichl, U.Integrated cell-culture based MVA virus production process with perfusion mode for vaccines or gene therapyPresented at: 27th ESACT MeetingLisbon (Portugal), June 26, 2022.

Poster (3)

2022
Poster
Göbel, S., Dorn, M., Jaén Chavez, K., Jordan, I., Sandig, V., Altomonte, J., Genzel, Y., & Reichl, U.Production of a fusogenic oncolytic rVSV-NDV virus in perfusion processesPresented at: Vaccine Technology VIIISitges (Spain), June 12, 2022.
Poster
Göbel, S., Jordan, I., Sandig, V., Altomonte, J., Genzel, Y., & Reichl, U.Towards the production of a fusogenic oncolytic rVSV-NDV virus in perfusion modePresented at: 27th ESACT MeetingLisbon (Portugal), June 26, 2022.
Poster
Göbel, S., Kortum, F., Jaén Chavez, K., Jordan, I., Sandig, V., Altomonte, J., Genzel, Y., & Reichl, U.Production of a fusogenic oncolytic VSV-NDV virus: cell-line screening and process development in small-scale suspension culturesPresented at: Advancing Manufacture of Cell and Gene Therapies VIICoronado, CA (USA), February 6, 2022.
Go to Editor View